News

A recent study revealed improvements in sensitivity but highlighted disparities in diagnostic accuracy, particularly among non-specialists and in darker skin tones.

Alongside expert dermatologists, the NRS recently developed a Seal of Acceptance for skin care and cosmetic products clinically tested and evaluated for patients with rosacea.

Keep up with the latest headlines in dermatology from the past week, including biotech's potential role in alleviating symptoms of skin disease, new sun safety guidelines in Australia, and more.

The Skin Cancer Foundation’s initiative, Destination Healthy Skin, travels to various cities throughout the country in an RV, wherein volunteer dermatologists provide on-the-street, free-of-cost skin screenings.

Click here to answer this week’s acne poll.

ICYMI, this week we had news about Masterclasses in Dermatology, JNJ-2113's significant PASI and IGA responses for plaque psoriasis, Almirall's partnership with the Centre for Genomic Regulation, and more.

Shanna Miranti, MPAS, PA-C, shares updates on the status of roflumilast foam 0.3% and Cabtreo available in US pharmacies.

Both cream options were capable of reducing scores of itching, drying, burning, redness, and more.

Interim data from the clinical trial was presented in a poster at the South Beach Symposium, with itch reduction demonstrating immediacy and long-term capability.

For a patient with vitiligo who is concerned about potential flares, what might you recommend avoiding?

A discussion among roundtable participants revolved around the importance of effective communication, the impact of prolonged use of topical steroids, and the need for trust building in recommending novel treatment options.

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.

Biologics represent the pinnacle of scientific progress, engineered to precisely target conditions previously deemed untreatable. However, any dermatology provider who has prescribed one quickly learns of the immense barriers surrounding them.

The partnership is focused on exploring innovative therapeutic strategies to address AD.

For the third consecutive year, physician assistants ranked number 2 behind nurse practitioners in the individual healthcare sector listing.

Krystal Biotech’s B-VEC was administered as an eyedrop for a patient with dystrophic epidermolysis bullosa with cicatrizing conjunctivitis.

Data from the FRONTIER 1 clinical trial were recently published in the New England Journal of Medicine.

There’s nothing worse than having OTC products fight back against the progress we make with our prescription therapies.  

Exposure led to an increase in total plasma IgE levels but reduced epidermal thickening, mast cell number, and plasma histamine levels in the early stages of AD.

Decentralized clinical trials are emerging as a crucial avenue for transforming this gender bias and fostering inclusivity within health care research.

A team of dermatology physician assistants recently reviewed the current and future potential of genomic testing in the realm of dermatology.

The partnership and newly-established center will develop dermatological research and delve into skin aging, skin allergies, and inflammatory or eczematous conditions.

Researchers explored the efficacy of a multistep treatment strategy in a younger patient population.

The conference's course directors give a sneak peek of what in-person and virtual attendees will learn about AI, alternative medicine, surgical management of HS, and more.

The submission deadline for this year’s awards and grants is Friday, March 15, 2024. Award recipients will be notified in June 2024, and the grant period for all awards is 1 year beginning on July 1, 2024.

Investigators highlighted the importance of considering household second hand smoke exposure when evaluating adolescents with AD.

The Technology Breakthrough designation will enable health care providers to access exclusive pricing and terms for the solution in pediatric burn care.

Keep up with the latest headlines in dermatology from the past week, including the role of the US in hosting more than half of the world's skin cancer-related trials, new AAD guidelines for acne, and more.

Today is Women Physicians Day. We are celebrating women on our board who make positive strides in dermatology and strive to advance patient care.

ICYMI, this week we had news about VENT-03's potential as a small molecule therapeutic in dermatology, a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum, and more.